Six Months of Treatment with Risperidone May Be Associated with Nonsignificant Abnormalities of Liver Function Tests in Children and Adolescents: A Longitudinal, Observational Study from Turkey

Erdogan, Ayten; Karaman, Mehmet; Ozdemir, ESRA; Yurteri, Nihal; Tufan, Ali; Kurcer, Mehmet

doi:10.1089/cap.2009.0113

Six Months of Treatment with Risperidone May Be Associated with Nonsignificant Abnormalities of Liver Function Tests in Children and Adolescents: A Longitudinal, Observational Study from Turkey

Erdogan A., Karaman M. G., Ozdemir E., Yurteri N., Tufan A. E., Kurcer M. A.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, cilt.20, sa.5, ss.407-413, 2010 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20 Sayı: 5
Basım Tarihi: 2010
Doi Numarası: 10.1089/cap.2009.0113
Dergi Adı: JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.407-413
Erciyes Üniversitesi Adresli: Hayır

Özet

Objective: Risperidone is a promising agent for the treatment of schizophrenia, Tourette's disorder, mood disorders, and disruptive behavior disorders in young populations. However, adverse effects of risperidone may take a long time to emerge. The objective of this study was to investigate the changes in the liver function tests (LFTs) associated with more than 6 months of risperidone treatment in children and adolescents.